Pioneering Stem Cell Nutrition Company Elevating Wellness and Prosperity Together
Approach and Global Impact Solidify Stemtech's Position as Leader in Stem Cell NutritionNAPLES, FL / ACCESSWIRE / September 5, 2023...
Day: September 5, 2023
Tribun Health Secures €15 Million Euros in Series B Funding Round Led by Autonomous Patient Fund of Bpifrance With LBO, Owkin and Vivalto Family as Prominent Investors
PARIS, FRANCE / ACCESSWIRE / September 5, 2023 / Tribun Health, a leading innovator in the field of digital pathology,...
Protagonist Therapeutics to Present at Upcoming Investor Conferences
NEWARK, CA / ACCESSWIRE / September 5, 2023 / Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or "the Company") today announced that...
Novobeing Launches Multi-Sensory Well-Being Applicaton on Meta Quest
New app aims to revolutionize mental well-being through cutting-edge immersive experiences that make mindfulness meditation and breathwork more engaging &...
Ainos Commences Shipping its VELDONA Pet Cytoprotein Supplements in Taiwan
First Batch of 300,000 Units to be Fully Delivered in OctoberAinos Has Expanded Distribution in Multiple Channels and Plans to...
Virbac : Declaration of the number of shares and voting rights 06/2023
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information...
Viracta Therapeutics to Host R&D Day on October 4, 2023
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on...
Immutep to Participate in September Investor Conferences
SYDNEY, AUSTRALIA, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage...
Folia Health Reinforces Commitment to Autoimmune and Neurological Conditions: Announcing the Expansion of Multiple Sclerosis, Huntington’s Disease, and Myasthenia Gravis User Cohorts
Folia Health Announces Expansion of HD, MS, MG cohorts By expanding their patient and caregiver user cohorts living with these...
Artelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13th
SOLANA BEACH, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on...
Solera Introduces Weight Loss Solution to Help Payers and Employers Manage Skyrocketing GLP-1 Demand While Empowering Individuals to Make Informed Choices
GLP-1 Support from Solera can save tens of millions by streamlining step therapy and the prior authorization process for health...
Solid Biosciences to Participate at Upcoming Investor Conferences
CHARLESTOWN, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for...
Virbac : Declaration of the number of shares and voting rights 05/2023
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information...
Virbac : Declaration of the number of shares and voting rights 04/2023
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information...
Avenue Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference
MIAMI, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...
ReWalk Robotics Announces Additional Change to Board of Directors
Number of Director Seats to be Reduced to SevenMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Sept. 05, 2023 (GLOBE...
Eterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors
Dorothy Clarke Dorothy Clarke CAMBRIDGE, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the...
Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
CHARLOTTESVILLE, Va., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage...
SomaLogic expands agreement with Novo Nordisk to 2025
Novo Nordisk will extend its use of SomaLogic’s innovative proteomics technologies for research in cardiometabolic and other diseasesBOULDER, Colo., Sept....
IMUNON to Participate in the H.C. Wainwright Global Investment Conference
LAWRENCEVILLE, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage biotechnology company, announces that management will...